Clinical Trial Update: Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating nivolumab for melanoma patients with in-transit metastases treated by isolated limb perfusion, currently in Phase 1/2 and recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Melanoma, In-Transit Metastasis | Phase 1, Phase 2 | Status: RECRUITING